Evidence mapPaperPMID 41665962Full record

ArticleJCI insight2026

IFN-γ-induced trained immunity enhances killing of priority pathogens in healthy and genetically vulnerable individuals.

Dearbhla M Murphy, Isabella Batten, Aoife O'Farrell, Simon R Carlile, Sinead A O'Rourke, Chloe Court, Brenda Morris, Gina Leisching, Gráinne Jameson, Sarah A Connolly and 19 more

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Dearbhla M MurphySchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Isabella BattenSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Aoife O'FarrellDepartment of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Simon R CarlileSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Sinead A O'RourkeSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Chloe CourtSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Brenda MorrisSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Gina LeischingSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Gráinne JamesonSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Sarah A ConnollySchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Adam H DyerSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
John P McGrathSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Emma McNallySchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Olivia Sandby-ThomasSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Anjali YennemadiSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Conor M FinlaySchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Clíona Ní CheallaighSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Jean DunneSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Cilian Ó MaoldomhnaighSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Laura E GleesonSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Aisling DunneSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Nollaig BourkeSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Reinout van CrevelDepartment of Internal Medicine and Radboud Community for Infectious Diseases, Radboud University Medical Centre, Nijmegen, Netherlands.
Donal J CoxSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Niall ConlonSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Arjun RajDepartment of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Rachel M McLoughlinSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Joseph KeaneSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Sharee A BasdeoSchool of Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, University of Dublin, Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious diseases remain a global health challenge, driven by increasing antimicrobial resistance and the threat of emerging epidemics. Mycobacterium tuberculosis and Staphylococcus aureus are leading causes of mortality worldwide. Trained immunity - a form of innate immune memory - offers a promising approach to enhance pathogen clearance. Here, we demonstrate that IFN-γ induces trained immunity in human monocytes through a mechanism involving mTORC1 activation, glutaminolysis, and epigenetic remodeling. Macrophages derived from IFN-γ-trained monocytes exhibited increased glycolytic activity with enhanced cytokine and chemokine responses upon stimulation or infection. Crucially, trained macrophages had increased production of reactive oxygen species, which mediated enhanced bactericidal activity against methicillin-resistant S. aureus and M. tuberculosis. Furthermore, ATAC-sequencing analysis of IFN-γ-trained macrophages revealed increased chromatin accessibility in regions associated with host defense. Last, IFN-γ training restored impaired innate responses in macrophages from individuals homozygous for the TIRAP 180L polymorphism, a genetic variant associated with increased susceptibility to infection. These findings establish IFN-γ as a potent inducer of trained immunity in human monocytes and support its potential as a host-directed strategy to strengthen antimicrobial defenses, particularly in genetically susceptible individuals and high-risk clinical contexts.

Indexed as

Interferon-gammaMacrophagesTrained ImmunityHumansImmunity, InnateMethicillin-Resistant Staphylococcus aureusMonocytesMycobacterium tuberculosisReactive Oxygen SpeciesInterferon-gammaReactive Oxygen SpeciesBacterial infectionsImmunologyInfectious diseaseMacrophagesPreventative medicine

Identifiers

PMID41665962
PMCPMC13043095

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.